JAMES N WILSON
CIK 1236387 · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.58M
Companies
2
Total Filings
83
Lifetime Open-Market Net
-$3.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Director | 200,000 | $82.91 | $16.58M | -$3.16M | 67 | 2026-05-29 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 2,000 | — | — | -$658.8K | 16 | 2009-04-07 |
Recent Filings · Page 5 of 9
83 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-06 | CORT | Mixed | −122,000 | -$45.5K | EDGAR |
| 2015-06-03 | CORT | Mixed | — | -$46.2K | EDGAR |
| 2015-05-11 | CORT | Mixed | — | -$44.1K | EDGAR |
| 2015-04-03 | CORT | Mixed | — | -$40.9K | EDGAR |
| 2015-03-24 | CORT | Mixed | +9,293 | -$4 | EDGAR |
| 2015-02-23 | CORT | Grant (A) | — | $0 | EDGAR |
| 2013-02-01 | CORT | Grant (A) | — | $0 | EDGAR |
| 2011-12-01 | CORT | Sell (S) | −15,000 | -$46.3K | EDGAR |
| 2011-11-02 | CORT | Sell (S) | −15,000 | -$45.7K | EDGAR |
| 2011-10-05 | CORT | Sell (S) | −15,000 | -$45.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.